StoryResearch
Biren allocates 85% of IPO proceeds toward BR20X development and manufacturing
In its IPO prospectus, Biren disclosed that 85% of the HK$5.58B raise (roughly US$610M) will fund research and development and manufacturing capacity expansion. The remainder covers commercialization and working capital. The company targets tape-out of BR20X by Q4 2026, with mass deployment planned for 2027, adding lower-precision compute engines (FP8/FP4) to support inference workloads.